iHuman Income Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	779.08	807.02	922.2	1,018	985.52	944.72
Revenue Growth (YoY)	-13.21%	-12.49%	-9.42%	3.31%	4.32%	77.61%
Cost of Revenue	253.27	259.41	282.05	296.87	294.34	284.1
Gross Profit	525.81	547.61	640.15	721.27	691.17	660.62
Selling, General & Admin	281.18	272.41	320.48	303.84	266.11	299.54
Research & Development	209.56	208.44	247.76	257.55	313.48	415.33
Total Operating Expenses	490.74	480.85	568.24	561.38	579.59	714.87
Operating Income	35.07	66.76	71.91	159.89	111.58	-54.25
Total Non-Operating Income (Expense)	41.64	35.03	38.69	42.69	21.19	17.05
Pretax Income	76.72	101.79	110.6	202.57	132.77	-37.2
Provision for Income Taxes	3.32	6.39	12.01	21.67	22.95	-0.15
Net Income	73.4	95.4	98.59	180.91	109.82	-37.05
Net Income to Common	73.4	95.4	98.59	180.91	109.82	-37.05
Net Income Growth	-28.60%	-3.23%	-45.50%	64.73%	-	-
Shares Outstanding (Basic)	51	51	52	53	53	53
Shares Outstanding (Diluted)	53	54	54	55	54	53
Shares Change (YoY)	-1.33%	-1.32%	-0.94%	1.32%	1.34%	17.80%
EPS (Basic)	1.43	1.85	1.90	3.45	2.05	-0.70
EPS (Diluted)	1.38	1.80	1.80	3.30	2.05	-0.70
EPS Growth	-27.37%	-	-45.45%	60.98%	-	-
Free Cash Flow	-	46.41	51.1	165.61	181.88	5.93
Free Cash Flow Growth	-	-9.17%	-69.15%	-8.94%	2966.57%	-97.14%
Free Cash Flow Per Share	-	0.87	0.94	3.02	3.37	0.11
Gross Margin	67.49%	67.86%	69.42%	70.84%	70.13%	69.93%
Operating Margin	4.50%	8.27%	7.80%	15.70%	11.32%	-5.74%
Profit Margin	9.42%	11.82%	10.69%	17.77%	11.14%	-3.92%
FCF Margin	-	5.75%	5.54%	16.27%	18.46%	0.63%
EBITDA	35.07	74.5	85.57	171.58	122.41	-47.83
EBITDA Margin	4.50%	9.23%	9.28%	16.85%	12.42%	-5.06%
EBIT	35.07	66.76	71.91	159.89	111.58	-54.25
EBIT Margin	4.50%	8.27%	7.80%	15.70%	11.32%	-5.74%
Effective Tax Rate	4.32%	6.27%	10.86%	10.70%	17.29%	0.39%

SEC Filings: 10-K · 10-Q